Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
A phosphodiesterase inhibitor is a drug that blocks one or more of the five subtypes of the enzyme phosphodiesterase (PDE), thereby preventing the inactivation of the intracellular second messengers cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) by the respective PDE subtype(s).
PDE inhibitor drugs are also used to treat various other medical conditions such as autoimmune indications, ulcerative colitis, and others. However, the increasing incidence of ED across the world will boost the global phosphodiesterase inhibitors market growth during the forecast period.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Phosphodiesterase (PDE) inhibitors market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Phosphodiesterase (PDE) inhibitors market. Detailed analysis of key players, along with key growth strategies adopted by Phosphodiesterase (PDE) inhibitors industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Bayer AG
GlaxoSmithKline Plc
Pfizer Inc
Eli Lilly and Co
Vivus Inc
By Type:
PDE1 Selective Inhibitors
PDE2 Selective Inhibitors
PDE3 Selective Inhibitors
PDE4 selective inhibitors
PDE5 selective inhibitors
PDE7 selective inhibitors
PDE10 selective inhibitors
By End-User:
Oral
Topical
Other
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Phosphodiesterase (PDE) inhibitors Market
-
1.3 Market Segment by Type
-
1.3.1 China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE1 Selective Inhibitors from 2016 to 2027
-
1.3.2 China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE2 Selective Inhibitors from 2016 to 2027
-
1.3.3 China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE3 Selective Inhibitors from 2016 to 2027
-
1.3.4 China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE4 selective inhibitors from 2016 to 2027
-
1.3.5 China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE5 selective inhibitors from 2016 to 2027
-
1.3.6 China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE7 selective inhibitors from 2016 to 2027
-
1.3.7 China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE10 selective inhibitors from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of Oral from 2016 to 2027
-
1.4.2 China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of Topical from 2016 to 2027
-
1.4.3 China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Phosphodiesterase (PDE) inhibitors Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Phosphodiesterase (PDE) inhibitors by Major Types
-
3.4.1 Market Size and Growth Rate of PDE1 Selective Inhibitors
-
3.4.2 Market Size and Growth Rate of PDE2 Selective Inhibitors
-
3.4.3 Market Size and Growth Rate of PDE3 Selective Inhibitors
-
3.4.4 Market Size and Growth Rate of PDE4 selective inhibitors
-
3.4.5 Market Size and Growth Rate of PDE5 selective inhibitors
-
3.4.6 Market Size and Growth Rate of PDE7 selective inhibitors
-
3.4.7 Market Size and Growth Rate of PDE10 selective inhibitors
4 Segmentation of Phosphodiesterase (PDE) inhibitors Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Phosphodiesterase (PDE) inhibitors by Major End-Users
-
4.4.1 Market Size and Growth Rate of Phosphodiesterase (PDE) inhibitors in Oral
-
4.4.2 Market Size and Growth Rate of Phosphodiesterase (PDE) inhibitors in Topical
-
4.4.3 Market Size and Growth Rate of Phosphodiesterase (PDE) inhibitors in Other
5 Market Analysis by Regions
-
5.1 China Phosphodiesterase (PDE) inhibitors Production Analysis by Regions
-
5.2 China Phosphodiesterase (PDE) inhibitors Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Phosphodiesterase (PDE) inhibitors Landscape Analysis
-
6.1 North China Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major Types
-
6.2 North China Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major End-Users
7 Central China Phosphodiesterase (PDE) inhibitors Landscape Analysis
-
7.1 Central China Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major Types
-
7.2 Central China Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major End-Users
8 South China Phosphodiesterase (PDE) inhibitors Landscape Analysis
-
8.1 South China Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major Types
-
8.2 South China Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major End-Users
9 East China Phosphodiesterase (PDE) inhibitors Landscape Analysis
-
9.1 East China Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major Types
-
9.2 East China Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major End-Users
10 Northeast China Phosphodiesterase (PDE) inhibitors Landscape Analysis
-
10.1 Northeast China Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major Types
-
10.2 Northeast China Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major End-Users
11 Southwest China Phosphodiesterase (PDE) inhibitors Landscape Analysis
-
11.1 Southwest China Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major Types
-
11.2 Southwest China Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major End-Users
12 Northwest China Phosphodiesterase (PDE) inhibitors Landscape Analysis
-
12.1 Northwest China Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major Types
-
12.2 Northwest China Phosphodiesterase (PDE) inhibitors Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Bayer AG
-
13.1.1 Bayer AG Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 GlaxoSmithKline Plc
-
13.2.1 GlaxoSmithKline Plc Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Pfizer Inc
-
13.3.1 Pfizer Inc Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Eli Lilly and Co
-
13.4.1 Eli Lilly and Co Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Vivus Inc
-
13.5.1 Vivus Inc Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE1 Selective Inhibitors from 2016 to 2027
-
Figure China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE2 Selective Inhibitors from 2016 to 2027
-
Figure China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE3 Selective Inhibitors from 2016 to 2027
-
Figure China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE4 selective inhibitors from 2016 to 2027
-
Figure China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE5 selective inhibitors from 2016 to 2027
-
Figure China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE7 selective inhibitors from 2016 to 2027
-
Figure China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of PDE10 selective inhibitors from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of Oral from 2016 to 2027
-
Figure China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of Topical from 2016 to 2027
-
Figure China Phosphodiesterase (PDE) inhibitors Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Phosphodiesterase (PDE) inhibitors Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Phosphodiesterase (PDE) inhibitors Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Phosphodiesterase (PDE) inhibitors
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Phosphodiesterase (PDE) inhibitors by Different Types from 2016 to 2027
-
Table Consumption Share of Phosphodiesterase (PDE) inhibitors by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of PDE1 Selective Inhibitors
-
Figure Market Size and Growth Rate of PDE2 Selective Inhibitors
-
Figure Market Size and Growth Rate of PDE3 Selective Inhibitors
-
Figure Market Size and Growth Rate of PDE4 selective inhibitors
-
Figure Market Size and Growth Rate of PDE5 selective inhibitors
-
Figure Market Size and Growth Rate of PDE7 selective inhibitors
-
Figure Market Size and Growth Rate of PDE10 selective inhibitors
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Phosphodiesterase (PDE) inhibitors by Different End-Users from 2016 to 2027
-
Table Consumption Share of Phosphodiesterase (PDE) inhibitors by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Oral
-
Figure Market Size and Growth Rate of Topical
-
Figure Market Size and Growth Rate of Other
-
Table China Phosphodiesterase (PDE) inhibitors Production by Regions
-
Table China Phosphodiesterase (PDE) inhibitors Production Share by Regions
-
Figure China Phosphodiesterase (PDE) inhibitors Production Share by Regions in 2016
-
Figure China Phosphodiesterase (PDE) inhibitors Production Share by Regions in 2021
-
Figure China Phosphodiesterase (PDE) inhibitors Production Share by Regions in 2027
-
Table China Phosphodiesterase (PDE) inhibitors Consumption by Regions
-
Table China Phosphodiesterase (PDE) inhibitors Consumption Share by Regions
-
Figure China Phosphodiesterase (PDE) inhibitors Consumption Share by Regions in 2016
-
Figure China Phosphodiesterase (PDE) inhibitors Consumption Share by Regions in 2021
-
Figure China Phosphodiesterase (PDE) inhibitors Consumption Share by Regions in 2027
-
Table North China Phosphodiesterase (PDE) inhibitors Consumption by Types from 2016 to 2027
-
Table North China Phosphodiesterase (PDE) inhibitors Consumption Share by Types from 2016 to 2027
-
Figure North China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2016
-
Figure North China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2021
-
Figure North China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2027
-
Table North China Phosphodiesterase (PDE) inhibitors Consumption by End-Users from 2016 to 2027
-
Table North China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure North China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2016
-
Figure North China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2021
-
Figure North China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2027
-
Table Central China Phosphodiesterase (PDE) inhibitors Consumption by Types from 2016 to 2027
-
Table Central China Phosphodiesterase (PDE) inhibitors Consumption Share by Types from 2016 to 2027
-
Figure Central China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2016
-
Figure Central China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2021
-
Figure Central China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2027
-
Table Central China Phosphodiesterase (PDE) inhibitors Consumption by End-Users from 2016 to 2027
-
Table Central China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2016
-
Figure Central China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2021
-
Figure Central China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2027
-
Table South China Phosphodiesterase (PDE) inhibitors Consumption by Types from 2016 to 2027
-
Table South China Phosphodiesterase (PDE) inhibitors Consumption Share by Types from 2016 to 2027
-
Figure South China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2016
-
Figure South China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2021
-
Figure South China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2027
-
Table South China Phosphodiesterase (PDE) inhibitors Consumption by End-Users from 2016 to 2027
-
Table South China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure South China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2016
-
Figure South China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2021
-
Figure South China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2027
-
Table East China Phosphodiesterase (PDE) inhibitors Consumption by Types from 2016 to 2027
-
Table East China Phosphodiesterase (PDE) inhibitors Consumption Share by Types from 2016 to 2027
-
Figure East China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2016
-
Figure East China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2021
-
Figure East China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2027
-
Table East China Phosphodiesterase (PDE) inhibitors Consumption by End-Users from 2016 to 2027
-
Table East China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure East China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2016
-
Figure East China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2021
-
Figure East China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2027
-
Table Northeast China Phosphodiesterase (PDE) inhibitors Consumption by Types from 2016 to 2027
-
Table Northeast China Phosphodiesterase (PDE) inhibitors Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2016
-
Figure Northeast China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2021
-
Figure Northeast China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2027
-
Table Northeast China Phosphodiesterase (PDE) inhibitors Consumption by End-Users from 2016 to 2027
-
Table Northeast China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2016
-
Figure Northeast China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2021
-
Figure Northeast China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2027
-
Table Southwest China Phosphodiesterase (PDE) inhibitors Consumption by Types from 2016 to 2027
-
Table Southwest China Phosphodiesterase (PDE) inhibitors Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2016
-
Figure Southwest China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2021
-
Figure Southwest China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2027
-
Table Southwest China Phosphodiesterase (PDE) inhibitors Consumption by End-Users from 2016 to 2027
-
Table Southwest China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2016
-
Figure Southwest China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2021
-
Figure Southwest China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2027
-
Table Northwest China Phosphodiesterase (PDE) inhibitors Consumption by Types from 2016 to 2027
-
Table Northwest China Phosphodiesterase (PDE) inhibitors Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2016
-
Figure Northwest China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2021
-
Figure Northwest China Phosphodiesterase (PDE) inhibitors Consumption Share by Types in 2027
-
Table Northwest China Phosphodiesterase (PDE) inhibitors Consumption by End-Users from 2016 to 2027
-
Table Northwest China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2016
-
Figure Northwest China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2021
-
Figure Northwest China Phosphodiesterase (PDE) inhibitors Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Bayer AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG
-
Figure Sales and Growth Rate Analysis of Bayer AG
-
Figure Revenue and Market Share Analysis of Bayer AG
-
Table Product and Service Introduction of Bayer AG
-
Table Company Profile and Development Status of GlaxoSmithKline Plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc
-
Table Product and Service Introduction of GlaxoSmithKline Plc
-
Table Company Profile and Development Status of Pfizer Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc
-
Figure Sales and Growth Rate Analysis of Pfizer Inc
-
Figure Revenue and Market Share Analysis of Pfizer Inc
-
Table Product and Service Introduction of Pfizer Inc
-
Table Company Profile and Development Status of Eli Lilly and Co
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Co
-
Figure Sales and Growth Rate Analysis of Eli Lilly and Co
-
Figure Revenue and Market Share Analysis of Eli Lilly and Co
-
Table Product and Service Introduction of Eli Lilly and Co
-
Table Company Profile and Development Status of Vivus Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vivus Inc
-
Figure Sales and Growth Rate Analysis of Vivus Inc
-
Figure Revenue and Market Share Analysis of Vivus Inc
-
Table Product and Service Introduction of Vivus Inc
-
